CD274 and neoplasm: Notably, the observed strong correlation between PD-L1 expression and MSI-high status reinforces emerging evidence of immunogenic tumor profiles in this population and supports the clinical relevance of dual biomarker testing to guide immunotherapy decisions in Brazilian patients.